Table 1.
Parkinson patients at the time of evaluation.
| Patient | Age | Time since diagnosis | Time since DBS implantation | PD medication | UPDRS score Off | UPDRS score On |
|---|---|---|---|---|---|---|
| 1 | 67 | 5 years | 10 months | L-dopa, rotigotine | 47 | 22 |
| 2 | 65 | 12 years | 5 months | L-dopa, rotigotine, amantadine | 53 | 27 |
| 3 | 44 | 5 years | 6 months | L-dopa, biperidone | 39 | 29 |
| 4 | 76 | 10 years | 12 months | L-dopa, rotigotine, amantadine | 42 | 37 |
| 5 | 59 | 5 years | 11 months | L-dopa, rotigotine | 57 | 41 |
| 6 | 63 | 10 years | 46 months | L-dopa, rotigotine, rasagiline | 40 | 25 |
PD medication doses: L-dopa ranged from 400 to 1000 mg per day, rotigotine 4–8 mg per day, amantadine ranged from 100 to 300 mg per day, and rasagiline 1 mg per day.